LILLIAN PENIX: Open Payments
NPI 1841968120 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 40 payments from 17 companies in 2025. Trend: 2023 $2,297 · 2024 $2,045 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 4 | $161 |
| Janssen Biotech, Inc. | 6 | $128 |
| Ferring Pharmaceuticals Inc. | 6 | $107 |
| Telix Pharmaceuticals | 4 | $72 |
| PFIZER INC. | 3 | $61 |
| BIOPROTECT MEDICAL, INC. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| DENTSPLY IH AB | 1 | $49 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $43 |
Products named: PROVENGE, ERLEADA, ADSTILADRIN, XTANDI, ILLUCCIX, BIOPROTECT BALLOON IMPLANT SYSTEM, KEYTRUDA, LOFRIC.
Industry payments across NY — which companies pay providers there.
